Natalizumab Treatment for Relapsing Multiple Sclerosis Stabilises Normal-Appearing White Matter Microstructure: A One-Year Prospective Ultra-High-Field Quantitative Imaging Study

(1) Background: Natalizumab dramatically reduces relapses and MRI inflammatory activity (new lesions and enhancing lesions) in multiple sclerosis (MS). Chemical exchange saturation transfer (CEST) MRI can explore brain tissue in vivo with high resolution and sensitivity. We investigated if natalizum...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanasescu, Radu, Mougin, Olivier, Chou, I-Jun, Al-Radaideh, Ali, Jerca, Oltita P., Lim, Su-Yin, Gowland, Penny, Constantinescu, Cris S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605806/
https://www.ncbi.nlm.nih.gov/pubmed/37891832
http://dx.doi.org/10.3390/brainsci13101464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605806/
https://www.ncbi.nlm.nih.gov/pubmed/37891832
http://dx.doi.org/10.3390/brainsci13101464

Ejemplares similares